265 related articles for article (PubMed ID: 30115080)
1. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
Fu H; Zhang X; Han T; Mo X; Wang Y; Chen H; Han W; Wang J; Wang F; Yan C; Zhang Y; Sun Y; Liu K; Huang X; Xu L
Bone Marrow Transplant; 2019 Aug; 54(8):1310-1318. PubMed ID: 30664724
[TBL] [Abstract][Full Text] [Related]
3. Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children.
Uria-Oficialdegui ML; Alonso L; Benitez-Carabante MI; Renedo B; Oliveras M; Diaz-de-Heredia C
Pediatr Transplant; 2021 Jun; 25(4):e14010. PubMed ID: 33742757
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin.
Li Y; Kong F; Bai G; Jiang Y; Zhang W; Sun X; Sui X; Li Y; Ding M; Yuan D; Wang X; Fang X
Front Immunol; 2024; 15():1340908. PubMed ID: 38650933
[TBL] [Abstract][Full Text] [Related]
5. Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.
Zhou M; Li T; Zhang P; Lai Y; Sheng L; Ouyang G
Ann Hematol; 2024 May; 103(5):1697-1704. PubMed ID: 38536476
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study.
Giammarco S; Sica S; Chiusolo P; Laurenti L; Sorá F; Martino M; Metafuni E; Busca A; Risitano A; Vallejo C; Bacigalupo A
Int J Hematol; 2021 Aug; 114(2):228-234. PubMed ID: 33886103
[TBL] [Abstract][Full Text] [Related]
7. [Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation].
Ma YR; Huang XJ; Mo XD; Han W; Yan CH; Chen Y; Ji Y; Chen YY; Wang Y; Zhang XH; Liu KY; Xu LP
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1065-1069. PubMed ID: 28088971
[TBL] [Abstract][Full Text] [Related]
8. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
Wen B; Zhang X; Chen S; Fan J; Yang S; Cai Y; Wang P; Zhang Q; Gu Q; Du X
Hematol Oncol; 2022 Oct; 40(4):777-786. PubMed ID: 35554955
[TBL] [Abstract][Full Text] [Related]
9. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
[TBL] [Abstract][Full Text] [Related]
11. Eltrombopag for post-transplant cytopenias due to poor graft function.
Marotta S; Marano L; Ricci P; Cacace F; Frieri C; Simeone L; Trastulli F; Vitiello S; Cardano F; Pane F; Risitano AM
Bone Marrow Transplant; 2019 Aug; 54(8):1346-1353. PubMed ID: 30679824
[TBL] [Abstract][Full Text] [Related]
12. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
Kilic Gunes E; Yigit Kaya S; Yaman F; Yeniay MK; Vural K; Comert M; Sevindik OG; Andic N; Dagdas S; Nizam Ozen I; Kaynar L; Yavasoglu F; Ozet G; Karakus V; Ayli M
Leuk Res; 2024 May; 140():107484. PubMed ID: 38520796
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.
Busca A; Dellacasa C; Giaccone L; Manetta S; Biale L; Godio L; Aydin S; Festuccia M; Brunello L; Bruno B
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1765-1770. PubMed ID: 29684566
[TBL] [Abstract][Full Text] [Related]
14. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
15. Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients.
Ahn HJ; Byun JM; Kim I; Youk J; Koh Y; Shin DY; Hong J; Yoon SS
J Korean Med Sci; 2022 Feb; 37(6):e48. PubMed ID: 35166084
[TBL] [Abstract][Full Text] [Related]
16. Eltrombopag use in a patient with Wiskott-Aldrich syndrome.
Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468
[TBL] [Abstract][Full Text] [Related]
17. Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.
Yuan C; Boyd AM; Nelson J; Patel RD; Varela JC; Goldstein SC; Ahmad S; Zhu X; Mori S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1320-1324. PubMed ID: 30710685
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
Nampoothiri RV; Ho L; McEwan C; Pasic I; Lam W; Law AD; Michelis FV; Thyagu S; Kim DDH; Gerbitz A; Viswabandya A; Lipton JH; Mattsson J; Kumar R
Bone Marrow Transplant; 2021 Oct; 56(10):2471-2476. PubMed ID: 34108675
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment of secondary graft failure after allogeneic stem cell transplantation for aplastic anemia with eltrombopag].
Takano K; Izumi T; Kawamura T; Horiuchi T; Kobayashi S; Sato K; Kimura F
Rinsho Ketsueki; 2022; 63(3):177-181. PubMed ID: 35387929
[TBL] [Abstract][Full Text] [Related]
20. Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Ahmed S; Bashir Q; Bassett RL; Ullah F; Aung F; Valdez BC; Alousi AM; Hosing C; Kebriaei P; Khouri I; Marin D; Nieto Y; Olson A; Oran B; Qazilbash MH; Rezvani K; Mehta R; Shpall EJ; Ciurea S; Andersson BS; Champlin RE; Popat UR
Am J Hematol; 2024 Apr; 99(4):562-569. PubMed ID: 38314663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
